These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 17143970

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K.
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M, Gladman DD, Ibañez D, Urowitz MB.
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Moderate and severe neutropenia in patients with systemic lupus erythematosus.
    Martínez-Baños D, Crispín JC, Lazo-Langner A, Sánchez-Guerrero J.
    Rheumatology (Oxford); 2006 Aug; 45(8):994-8. PubMed ID: 16484291
    [Abstract] [Full Text] [Related]

  • 12. Ovarian failure and flares of systemic lupus erythematosus.
    Mok CC, Wong RW, Lau CS.
    Arthritis Rheum; 1999 Jun; 42(6):1274-80. PubMed ID: 10366122
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC, Ho LY, Cheung MY, Yu KL, To CH.
    Scand J Rheumatol; 2009 Jun; 38(2):121-7. PubMed ID: 18991189
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
    Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Llorente L, Sánchez-Guerrero J.
    Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
    [Abstract] [Full Text] [Related]

  • 16. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus.
    Mikdashi J, Krumholz A, Handwerger B.
    Neurology; 2005 Jun 28; 64(12):2102-7. PubMed ID: 15985581
    [Abstract] [Full Text] [Related]

  • 17. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb 28; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

  • 18. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
    Mok CC, Lau CS, Wong RW.
    J Rheumatol; 2001 Apr 28; 28(4):766-71. PubMed ID: 11327248
    [Abstract] [Full Text] [Related]

  • 19. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.
    Scand J Rheumatol; 2007 Apr 28; 36(6):442-7. PubMed ID: 18092265
    [Abstract] [Full Text] [Related]

  • 20. Myelitis in systemic lupus erythematosus: clinical characteristics and effect in accrual damage. A single-center experience.
    Quintanilla-González L, Atisha-Fregoso Y, Llorente L, Fragoso-Loyo H.
    Lupus; 2017 Mar 28; 26(3):248-254. PubMed ID: 27480991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.